Vivekananda Budamagunta Selected Research

Vivekananda Budamagunta Research Topics

7	Neoplasms (Cancer) 01/2024 - 01/2020
3	Pancreatic Neoplasms (Pancreatic Cancer) 01/2023 - 01/2022
2	T-Cell Lymphoma (Lymphoma, T Cell) 08/2020 - 01/2020
1	Chemotherapy-Related Cognitive Impairment 01/2024
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2023
1	Cognitive Dysfunction 01/2023
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022
1	Colorectal Neoplasms (Colorectal Cancer) 01/2022
1	Thrombocytopenia (Thrombopenia) 01/2020

5	DT2216IBA 01/2023 - 01/2020
4	Proteolysis Targeting ChimeraIBA 01/2022 - 01/2020
3	snake venom protein C activatorIBA 01/2022 - 01/2020
2	sotorasibIBA 01/2023 - 01/2022
2	navitoclaxIBA 01/2023 - 01/2020
2	Annexin A5IBA 01/2022 - 01/2022
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2020
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2024
1	(5- (2,4- bis((3S)- 3- methylmorpholin- 4- yl)pyrido(2,3- d)pyrimidin- 7- yl)- 2- methoxyphenyl)methanolIBA 01/2023
1	Apoptosis Regulatory ProteinsIBA 01/2023
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2023
1	Dasatinib (BMS 354825)FDA Link 01/2023
1	QuercetinIBA 01/2023
1	Gemcitabine FDA Link 01/2022
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2020

1	Therapeutics 01/2022